Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.280
-0.010 (-0.44%)
At close: Mar 27, 2026
Mayne Pharma Group Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -83.23 | -93.84 | -174.23 | 117.25 | -281.29 | -208.42 |
Depreciation & Amortization | 68.43 | 67.7 | 67.14 | 70.47 | 78.95 | 65.7 |
Other Amortization | 5.86 | 5.08 | 4.48 | 5.32 | 3.43 | 4.3 |
Loss (Gain) From Sale of Assets | - | - | - | - | -3.68 | - |
Asset Writedown & Restructuring Costs | - | - | - | 74.44 | 192.02 | 229.32 |
Loss (Gain) From Sale of Investments | - | - | - | 3.06 | - | - |
Stock-Based Compensation | 2.93 | 3.96 | 4.09 | 7.03 | 5.6 | 7.74 |
Other Operating Activities | 28.27 | 28.77 | 97.81 | 50.49 | 6.63 | -26.18 |
Change in Accounts Receivable | -9.23 | 12.63 | 5.92 | 118.7 | -66.12 | -3.2 |
Change in Inventory | 11.44 | 25.81 | 25.59 | -12.13 | -2.41 | -25.92 |
Change in Accounts Payable | 4.26 | -36.85 | -39.76 | 45.32 | 60.73 | 16.4 |
Change in Other Net Operating Assets | -7.07 | 4.21 | -6.34 | -6.47 | -1.07 | -0.86 |
Operating Cash Flow | 21.65 | 17.47 | -15.3 | -42.71 | -7.21 | 58.86 |
Operating Cash Flow Growth | 5436.57% | - | - | - | - | -47.72% |
Capital Expenditures | -6.71 | -12.28 | -7.95 | -8.34 | -10.01 | -17.09 |
Divestitures | - | - | 6.85 | 132.75 | - | - |
Sale (Purchase) of Intangibles | -16.1 | -16.71 | -12.91 | -211.25 | -1.84 | -8.01 |
Sale (Purchase) of Real Estate | - | - | - | - | 5.17 | - |
Investment in Securities | 67.07 | -0.51 | 89.27 | -127.53 | - | - |
Other Investing Activities | -49.16 | -38.57 | -21.81 | 687.85 | -21.84 | -24.15 |
Investing Cash Flow | -4.9 | -68.07 | 53.45 | 473.49 | -28.53 | -49.25 |
Short-Term Debt Issued | - | - | - | 185.94 | - | - |
Long-Term Debt Issued | - | - | - | 41 | 216.3 | 196.43 |
Total Debt Issued | - | - | - | 226.93 | 216.3 | 196.43 |
Short-Term Debt Repaid | - | - | -10.95 | -239.88 | -171.52 | - |
Long-Term Debt Repaid | - | -3.85 | -3.72 | -362.61 | -7.77 | -225.26 |
Total Debt Repaid | -3.5 | -3.85 | -14.67 | -602.49 | -179.29 | -225.26 |
Net Debt Issued (Repaid) | -3.5 | -3.85 | -14.67 | -375.56 | 37.01 | -28.83 |
Repurchase of Common Stock | - | -0.15 | -10.93 | -6.22 | - | - |
Common Dividends Paid | - | - | - | -45.29 | - | - |
Other Financing Activities | 2.27 | 3.44 | 5.75 | -4.81 | -9.41 | -11.61 |
Financing Cash Flow | -1.23 | -0.56 | -19.85 | -431.89 | 27.6 | -40.44 |
Foreign Exchange Rate Adjustments | -1.88 | 0.93 | -0.85 | -2.94 | 6.82 | -8.98 |
Net Cash Flow | 13.64 | -50.23 | 17.45 | -4.06 | -1.31 | -39.81 |
Free Cash Flow | 14.94 | 5.19 | -23.25 | -51.05 | -17.22 | 41.77 |
Free Cash Flow Growth | - | - | - | - | - | -59.68% |
Free Cash Flow Margin | 3.67% | 1.27% | -5.99% | -27.81% | -10.96% | 10.42% |
Free Cash Flow Per Share | 0.19 | 0.07 | -0.29 | -0.62 | -0.21 | 0.53 |
Cash Interest Paid | 1.47 | 1.48 | 1.32 | 7.13 | 9.87 | 12.29 |
Cash Income Tax Paid | - | -13.21 | 0.11 | 4.04 | -7.29 | -10.87 |
Levered Free Cash Flow | -15.25 | -19.7 | 20.08 | -102.85 | -49.31 | 68.46 |
Unlevered Free Cash Flow | 6 | 1.67 | 38.8 | -99.75 | -43.93 | 74.17 |
Change in Working Capital | -0.6 | 5.81 | -14.59 | 145.42 | -8.88 | -13.59 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.